American Association for Cancer Research

2005 AACR Minority-Serving Institution Faculty Scholars in Cancer Research

Diana S-L. Chow, Ph.D., University of Houston, Houston, TX. Abstract # 1403. Evaluation of transdermal permeation and plasma protein binding of CZ48, lactone-stabilized camptothecin-C20-propionate, in vitro using microdialysis technique.

Carolyn B. Howard, Ph.D., Jackson State University, Jackson, MS. Abstract # 5221. Modulation of CYP1A2 Expression in Ethanol-Exposed Mice in Response to Treatment with Vernonia Amygdalina Extract.

Marie-Claude E. Jipguep, Ph.D., Howard University, Washington, DC.

Duane E. Johnson, Ph.D., Dillard University, New Orleans, LA. Abstract #5778. Novel DJ56 causes tumor reduction in ER+ breast cancer cells.

James W. Lillard, Jr. Ph.D., Morehouse School of Medicine, Atlanta, GA.

Barbara A. Lyons, Ph.D., New Mexico State University, Las Cruces, NM.

Josiah Ochieng, Ph.D., Meharry Medical College, Nashville, TN. Abstract # 172. Fetuin-A/annexin interaction is a critical growth signaling pathway in ovarian carcinoma cells.

Elijah O. Okegbile, Ph.D., Tuskegee University, Tuskegee, AL.

Gerhild Packert, Ph.D., Barry University, Miami Shores, FL.

Xiaowu Pang, Ph.D., Howard University, Washington, DC.

KiTani A. Parker-Johnson, Ph.D., Dillard University, New Orleans, LA. Abstract # 5059. The combination of Cox-2 and EGF serve as potential prognostic biomarkers for hormone refractory prostate cancer.

Teresa R. Petrino, Ph.D., Barry University, Miami Shores, FL.

Gary L. Sanford, Ph.D., Morehouse School of Medicine, Atlanta, GA.

Shailesh Singh, Ph.D., Morehouse School of Medicine, Atlanta, GA. Abstract # 2383. CXCL13 bone marrow and CXCR5 prostate cancer cell expression and functional roles in motility, adhesion and invasion.

Teshome E. Yehualaeshet, Ph.D., D.V.M., Tuskegee University, Tuskegee, AL. Abstract # 792.E xpression of survivin in canine mammary tumor.

Beatriz Zayas, Ph.D., Universidad Metropolitana, San Juan, PR.

Yanfei Zhou, Ph.D., Howard University, Washington, DC. Abstract # 538. Loperamide sensitizes multidrug resistant MCF-7 clone 10.3 human breast cancer cells to doxorubicin.